Viking Therapeutics Inc
NASDAQ:VKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
S
|
Saputo Inc
OTC:SAPIF
|
CA |
|
Spirax-Sarco Engineering PLC
LSE:SPX
|
UK |
|
Air Products and Chemicals Inc
NYSE:APD
|
US |
|
PhosAgro PAO
MOEX:PHOR
|
RU |
|
Syntara Ltd
ASX:SNT
|
AU |
|
Prospa Group Ltd
ASX:PGL
|
AU |
|
VF Corp
NYSE:VFC
|
US |
|
OpGen Inc
NASDAQ:OPGN
|
US |
Wall St Price Targets
VKTX Price Targets Summary
Viking Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VKTX is 95.09 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VKTX's stock price target?
Price Target
95.09
USD
According to Wall Street analysts, the average 1-year price target for
VKTX is 95.09 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.